UA95271C2 - Применение солей тиотропия для лечения персистирующей астмы средней тяжести - Google Patents

Применение солей тиотропия для лечения персистирующей астмы средней тяжести

Info

Publication number
UA95271C2
UA95271C2 UAA200809746A UAA200809746A UA95271C2 UA 95271 C2 UA95271 C2 UA 95271C2 UA A200809746 A UAA200809746 A UA A200809746A UA A200809746 A UAA200809746 A UA A200809746A UA 95271 C2 UA95271 C2 UA 95271C2
Authority
UA
Ukraine
Prior art keywords
treatment
tiotropium salts
persistent asthma
moderate persistent
asthma
Prior art date
Application number
UAA200809746A
Other languages
English (en)
Ukrainian (uk)
Inventor
Михаэль Энгель
Штефан Хайнрихс
Original Assignee
Бьёрингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35695896&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95271(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бьёрингер Ингельхайм Интернациональ Гмбх filed Critical Бьёрингер Ингельхайм Интернациональ Гмбх
Publication of UA95271C2 publication Critical patent/UA95271C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

В заявке описано применение солей тиотропия для приготовления лекарственного средства, предназначенное для лечения пациентов, страдающих персистирующей астмой средней тяжести.
UAA200809746A 2006-01-04 2006-12-22 Применение солей тиотропия для лечения персистирующей астмы средней тяжести UA95271C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06100055 2006-01-04

Publications (1)

Publication Number Publication Date
UA95271C2 true UA95271C2 (ru) 2011-07-25

Family

ID=35695896

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200809746A UA95271C2 (ru) 2006-01-04 2006-12-22 Применение солей тиотропия для лечения персистирующей астмы средней тяжести

Country Status (30)

Country Link
US (2) US20070155773A1 (ru)
EP (1) EP1971332B1 (ru)
JP (1) JP2009525950A (ru)
KR (1) KR20080083060A (ru)
CN (1) CN101355937A (ru)
AR (1) AR059126A1 (ru)
AT (1) ATE500825T1 (ru)
AU (1) AU2006334367B2 (ru)
BR (1) BRPI0620886A2 (ru)
CA (1) CA2634984C (ru)
CY (1) CY1111534T1 (ru)
DE (1) DE602006020620D1 (ru)
DK (1) DK1971332T3 (ru)
EA (1) EA015353B1 (ru)
EC (1) ECSP088588A (ru)
ES (1) ES2362306T3 (ru)
HR (1) HRP20110200T1 (ru)
IL (1) IL192602A (ru)
ME (1) ME01205B (ru)
MY (1) MY146362A (ru)
NO (1) NO20082439L (ru)
NZ (1) NZ570162A (ru)
PL (1) PL1971332T3 (ru)
PT (1) PT1971332E (ru)
RS (1) RS51703B (ru)
SI (1) SI1971332T1 (ru)
TW (1) TW200731976A (ru)
UA (1) UA95271C2 (ru)
WO (1) WO2007077162A1 (ru)
ZA (1) ZA200804436B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0614394A2 (pt) 2005-08-06 2011-03-29 Boehringer Ingelheim Int uso de sais de tiotrópio
WO2015065222A1 (ru) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Фармацевтический ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких, содержащий в качестве активного вещества микронизированный тиотропия бромид, и способ его получения
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
CN110876721A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 一种含有表面活性剂的噻托溴铵喷雾剂
CN110876720A (zh) * 2018-09-06 2020-03-13 天津金耀集团有限公司 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425539A (en) * 1942-10-31 1947-08-12 Aro Equipment Corp Coupling
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB0009583D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
US6908928B2 (en) * 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
BR0114584A (pt) * 2000-10-12 2003-08-26 Boehringer Ingelheim Pharma Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento
US6608055B2 (en) * 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6919325B2 (en) * 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
US7951557B2 (en) * 2003-04-27 2011-05-31 Protalix Ltd. Human lysosomal proteins from plant cell culture
SI1682542T1 (sl) * 2003-11-03 2010-04-30 Boehringer Ingelheim Int Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo
US7968717B2 (en) * 2003-11-03 2011-06-28 Boehringer Ingelhein International Gmbh Crystalline anhydrate with anticholinergic efficacy
JP5165244B2 (ja) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
AU2006244683A1 (en) * 2005-05-10 2006-11-16 Synergenz Bioscience Limited Methods and compositions for assessment of pulmonary function and disorders
AU2006248189A1 (en) * 2005-05-20 2006-11-23 Synergenz Bioscience Limited Methods of analysis of polymorphisms and uses thereof
BRPI0614394A2 (pt) * 2005-08-06 2011-03-29 Boehringer Ingelheim Int uso de sais de tiotrópio
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Also Published As

Publication number Publication date
AU2006334367A1 (en) 2007-07-12
ME01205B (me) 2013-03-20
EP1971332A1 (en) 2008-09-24
PL1971332T3 (pl) 2011-08-31
US20070155773A1 (en) 2007-07-05
WO2007077162A1 (en) 2007-07-12
AU2006334367B2 (en) 2012-11-08
CY1111534T1 (el) 2015-08-05
BRPI0620886A2 (pt) 2011-11-29
RS51703B (en) 2011-10-31
NO20082439L (no) 2008-08-04
SI1971332T1 (sl) 2011-05-31
AR059126A1 (es) 2008-03-12
CA2634984A1 (en) 2007-07-12
KR20080083060A (ko) 2008-09-12
DE602006020620D1 (de) 2011-04-21
ECSP088588A (es) 2008-07-30
EA200801629A1 (ru) 2008-12-30
ZA200804436B (en) 2008-12-31
TW200731976A (en) 2007-09-01
IL192602A (en) 2013-06-27
US20150224090A1 (en) 2015-08-13
HRP20110200T1 (hr) 2011-04-30
ATE500825T1 (de) 2011-03-15
ES2362306T3 (es) 2011-07-01
MY146362A (en) 2012-08-15
EP1971332B1 (en) 2011-03-09
IL192602A0 (en) 2009-09-22
CN101355937A (zh) 2009-01-28
PT1971332E (pt) 2011-03-18
CA2634984C (en) 2014-05-06
NZ570162A (en) 2011-09-30
DK1971332T3 (da) 2011-04-18
JP2009525950A (ja) 2009-07-16
EA015353B1 (ru) 2011-06-30

Similar Documents

Publication Publication Date Title
WO2010042471A3 (en) Medical devices for delivery of therapeutic agents to body lumens
WO2010014690A3 (en) Medical devices for therapeutic agent delivery
IL213407A (en) Use of combinations of drug factors to prepare combination therapy drugs
WO2009065406A3 (en) Novel cyclic hydrocarbon compounds for the treatment of diseases
IL250439A0 (en) Use of fingolimod, or a phosphate derivative thereof or a pharmaceutical acceptable salt thereof for the preparation of a drug for the treatment of multiple sclerosis
FI3494972T3 (fi) Dolutegraviirin ja lamivudiinin yhdistelmiä hiv-infektion hoitoon
IL180565A0 (en) An improved stopcock for administering medicaments into the patient's body
NZ596805A (en) Meningococcal fHBP polypeptides
NZ624059A (en) Therapeutic applications of activation of human antigen-presenting cells through dectin-1
NZ599928A (en) Use of pentosan polysulfate for treatment or prophylaxis of asthma
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
TW200616608A (en) Memantine as adjunctive treatment to atypical antipsychotics in schizophrenia patients
UA98136C2 (ru) Применение аклидиния для лечения респираторных заболеваний
BR112012016783A2 (pt) "usos do composto de naltrexona ou sal farmaceuticamente aceitável da mesma a bupropiona ou sal farmaceuticamente aceitável da mesma ou de composição dos mesmos e métodos para proporcionar terapia"
ZA201007391B (en) Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium in the blood
WO2009103476A8 (en) Antitumoral agents with a benzophenanthridine structure and formulations containing them
UA95271C2 (ru) Применение солей тиотропия для лечения персистирующей астмы средней тяжести
WO2010121675A3 (en) Thiazolyl-benzimidazoles
IL240394B (en) Use of alemtuzumab to prepare a drug for use as a secondary treatment in multiple sclerosis
PL2379066T3 (pl) Zastosowanie antagonistów opioidów do otrzymywania leku w leczeniu chorób zwyrodnieniowych siatkówki
WO2008051527A3 (en) Sustained release of agents for localized pain management
MX2008001506A (es) Uso de sales de triotropio en el tratamiento de asma severa persistente.
MY146657A (en) Use of 4-cyclopropylmethoxy-n- (3,5-dichloro-1-oxido-pyridin-4-yl)-5-(methoxy) pyridine-2-carboxamide for the treatment of spinal cord traumas
NZ603040A (en) Compound for treatment of respiratory condition or disease
NZ599227A (en) Therapeutic agent for chronic pain